Drug Database
Back to search

Switzerland· 58693008

NovoSeven 8 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung

A coagulation factor viia product containing eptacogum alfa (activatum), registered in Switzerland by Novo Nordisk Pharma AG and dispensed under Swissmedic category B. The same ATC class is registered in 11 of our 19 countries.

Cat B (Swissmedic)ATC B02BD08

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedNovoSeven 8 mg, Pulver und Lösungsmit…ATCB02BD08REGISTER NO.58693008PACKS LISTED0CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about eptacogum alfa (activatum)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Coagulation factor viia is registered in 11 of 19 countries.

Countries holding a registration under ATC B02BD08 (coagulation factor viia), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose
Search coagulation factor viia products by name

Coagulation factor viia · ATC B02BD08

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
eptacogum alfa (activatum)
Manufacturer
Novo Nordisk Pharma AG
Country
Switzerland (CH)
ATC code
B02BD08
ATC class
Coagulation factor VIIa
Swissmedic category
B
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for coagulation factor viia.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check coagulation factor viia against other medicinesHow interaction checks work

Coagulation factor viia · interactions on record

5 records

  • 2 severe
  • 2 moderate
  • 1 minor

Most severe, free to view

  • CarfilzomibL01XG02severe
  • CarfilzomibL01XX45severe
  • Faktor VIII-Inhibitor Bypass Aktivität - FEIBAB02BD03moderate
  • EmicizumabB02BX06moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Coagulation factor viia in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All coagulation factor viia products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Cevenfacta, Novoseven
  • Liechtenstein · Cevenfacta
  • Norway · Cevenfacta, Novoseven

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8e201a91-e270-4bc2-8c5d-b735807bdf46
GET /v1/drugs/8e201a91-e270-4bc2-8c5d-b735807bdf46?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}
API referenceMCP serverPlans

See everything about coagulation factor viia.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console